To Assess the Efficacy and Safety of Dual Anticoagulants i.e. Rivaroxaban Plus Aspirin and Clopidogrel Plus Aspirin in Patients Suffering From an Acute Coronary Syndrome
Condition: Acute Coronary Syndrome Interventions: Drug: Rivaroxaban 2.5 Mg Oral Tablet; Drug: Clopidogrel tablet; Drug: Aspirin tablet Sponsors: Sarmad Zahoor; University of Managemant and Technology, Pakistan; Mayo Hospital Lahore Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials